Publication:
Intramyocardial Hemorrhage: The Final Frontier for Preventing Heart Failure Post-Myocardial Infarction.

Simple item page
dc.contributor.authorBerry, Colin
dc.contributor.authorIbáñez, Borja
dc.contributor.funderBritish Heart Foundationes_ES
dc.contributor.funderUnión Europeaes_ES
dc.contributor.funderAbbottes_ES
dc.contributor.funderAstraZenecaes_ES
dc.contributor.funderBoehringer Ingelheim Fondses_ES
dc.contributor.funderGenetic Engineering Tech (Genentech)es_ES
dc.contributor.funderGlaxoSmithKlinees_ES
dc.contributor.funderGrupo Menarinies_ES
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España)es_ES
dc.contributor.funderFundación ProCNICes_ES
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)es_ES
dc.date.accessioned2023-04-26T14:16:01Z
dc.date.available2023-04-26T14:16:01Z
dc.date.issued2022-01-04
dc.description.peerreviewedSíes_ES
dc.description.sponsorshipDr Berry has received research funding from the British Heart Foundation grant (RE/18/6134217), Chief Scientist Office, EPSRC (EP/R511705/1, EP/S030875/1), European Union (754946-2), Medical Research Council (MR/S018905/1), and UKRI (MC/PC/20014); and is employed by the University of Glasgow, which holds consultancy and research agreements for his work with Abbott Vascular, AstraZeneca, Boehringer Ingelheim, Causeway Therapeutics, Coroventis, Genentech, GlaxoSmithKline, HeartFlow, Menarini, Neovasc, Siemens Healthcare, and Valo Health. Dr Ibanez is supported by the European Commission (ERC-CoG grant No 819775) and by the Spanish Ministry of Science and Innovation (MCN; ‘RETOS 2019’ grant No PID2019- 107332RB-I00). The CNIC is supported by the ISCIII, the Ministry of Science and Innovation, and the Pro CNIC Foundation. CNIC is a Severo Ochoa Center of Excellence.es_ES
dc.format.number1es_ES
dc.format.page49es_ES
dc.format.volume79es_ES
dc.identifier.citationJ Am Coll Cardiol. 2022 Jan 4;79(1):49-51.es_ES
dc.identifier.doi10.1016/j.jacc.2021.11.002es_ES
dc.identifier.e-issn1558-3597es_ES
dc.identifier.journalJournal of the American College of Cardiologyes_ES
dc.identifier.pubmedID34991788es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15902
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/EC/H2020/754946-2es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/EC/H2020/ERC/CoG/819775es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PID2019-107332RB-I00es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.jacc.2021.11.002es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Laboratorio Traslacional para la Imagen y Terapia Cardiovasculares_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshHeart Failurees_ES
dc.subject.meshMyocardial Infarctiones_ES
dc.subject.meshHemorrhagees_ES
dc.subject.meshHumanses_ES
dc.subject.meshMyocardial Reperfusiones_ES
dc.titleIntramyocardial Hemorrhage: The Final Frontier for Preventing Heart Failure Post-Myocardial Infarction.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication2cac8bb6-2bff-4bf6-8209-bdbd21781786
relation.isAuthorOfPublication.latestForDiscovery2cac8bb6-2bff-4bf6-8209-bdbd21781786

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Intramyocardial Hemorrhage J Am Coll Cardiol 2022.pdf
Size:
299.18 KB
Format:
Adobe Portable Document Format
Description:
Editorial Material
Download

Collections

Grupos de investigación